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Abstract
Background: Accurate prognosis is vital to the initiation of advance care planning particularly in a vulnerable, at risk 
population such as care home residents. The aim of this paper is to report on the revision and simplification of the MDS 
Mortality Rating Index (MMRI) for use in clinical practice to predict the probability of death in six months for care home 
residents.
Methods: The design was a secondary analysis of a US Minimum Data Set (MDS) for long term care residents using 
regression analysis to identify predictors of mortality within six months.
Results: Using twelve easy to collect items, the probability of mortality within six months was accurately predicted 
within the MDS database. The items are: admission to the care home within three months; lost weight unintentionally 
in past three months; renal failure; chronic heart failure; poor appetite; male; dehydrated; short of breath; active cancer 
diagnosis; age; deteriorated cognitive skills in past three months; activities of daily living score.
Conclusion: A lack of recognition of the proximity of death is often blamed for inappropriate admission to hospital at 
the end of an older person's life. An accurate prognosis for older adults living in a residential or nursing home can 
facilitate end of life decision making and planning for preferred place of care at the end of life. The original MMRI was 
derived and validated from a large database of long term care residents in the USA. However, this simplification of the 
revised index (MMRI-R) may provide a means for facilitating prognostication and end of life discussions for application 
outside the USA where the MDS is not in use. Prospective testing is needed to further test the accuracy of the MMRI-R 
and its application in the UK and other non-MDS settings.
Background
A lack of recognition of the proximity of death is often
blamed for inappropriate admission to hospital at the end
of an older person's life. An accurate prognosis for older
adults living in a residential or nursing home can facili-
tate end of life decision making and planning for pre-
ferred place of care at the end of life. In the UK more than
80% of all deaths occur in the over 65 year old age group
and 68% are over 75 years. Furthermore, more than 80%
of UK deaths occur in institutions, including more than
20% in the care home setting [1]. Higginson [2] estimates
that about three quarters of all deaths are predictable
given they occur following a period of chronic illness.
Even though chronic illnesses and death are expected in
this population, there is still a reluctance to instigate end
of life care planning [3,4]. Planning, choice and commu-
nication are essential for supporting a good death in
which care is individualised and symptoms well managed.
Recognising that the patient is at the end of life is the
essential first step in accessing and providing excellent
palliative care.
General guidance has been provided in the Gold Stan-
dards Framework for Community Palliative Care [5,6]
prognosis but this has only limited application. However,
as Mckillop [7] states, there needs not only to be a general
prognosis based on tissue diagnosis and prognostic mark-
ers but also an individual prognosis specific to the person
sitting before the physician. What is needed now, to com-
plement and operationalise the GSF, is an individualised
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prognostic "marker" to help initiate these vital conversa-
tions about prognosis and EOL care.
The Minimum Data Set (MDS) is federally mandated in
the USA for monitoring the quality of long term care in
nursing homes certified by Medicare or Medicaid (Health
Care Financing Administration, 1995) [8]. The MDS has
been used previously to develop predictive models for
mortality of residents in relation to specific conditions [9-
11] as well as in general [12-15] including our own previ-
ous work [16].
In our article in 2005 we reported the development and
validation of a predictive model, the MDS Mortality Risk
Index (MMRI), of death in 6-months for older adults in
nursing homes was published [16]. The model was based
on a regression analysis of data from over 43,000 resi-
dents taken from Missouri's state MDS data. Two compo-
nents of the original scoring system made it difficult to
implement in practice without the aid of a computer pro-
gram. Several readers of the article contacted us to
enquire if a simplified system could be devised as they
wished to trial the scoring system in their own practice
and research and in settings where the MDS was not
available. Furthermore, it was found that when relying on
the usual MDS processing to get the score, too much time
had passed and residents had already passed away. Thus a
method of scoring that was not reliant on the MDS data
collection was needed [17]. The purpose of this paper is
to briefly summarise our original work; describe the deci-
sion making process associated with simplifying the
model; and then report on the performance of the revised
MMRI; the MMRI-R.
Development of the original MDS Mortality Risk Index
The MMRI was developed as a result of a series of studies
exploring items relating to mortality using the Minimum
Data Set (MDS) for long term care in the USA. Two
forms of the MDS are used. The full MDS is a question-
naire with around 400 items which is administered annu-
a l l y  o r  o n  a d m i s s i o n  t o  t h e  l o n g  t e r m  c a r e  f a c i l i t y .  A
shortened MDS is used quarterly and following any
adverse events. The data for the MDS is collected by des-
ignated nurses within each facility and are kept centrally
in each state and federally. The MDS is primarily used to
monitor care quality in long term care facilities and is
linked to funding through the Medicare and Medicaid
systems in the USA. The MDS includes a broad range of
items associated with the health and social wellbeing of
residents and although it was not originally designed for
research in long term care, the MDS provides a wealth of
data and research has developed alongside its use [17,18].
As palliative care researchers our interest began with a
single item in the MDS - J5c - that simply stated "The res-
ident has six or fewer months to live" to which a tick in
the box indicated the affirmative response and clearly
identifying residents known to be at the end of life (EOL).
Our first study used admission MDS data to describe res-
idents who were identified as EOL and compare their six
month survival with new admissions not so designated
[19]. We found only 4% of admissions were designated
EOL but that this item was a very good predictor with
50% of these residents dying in the first month of admis-
sion and only 17% still being alive 6-months later. Inter-
estingly, 5% of the non-EOL admissions also died in the
first month and 15% of them had also died by 6 months.
Although J5c was a reliable predictor it was not used fre-
quently enough to make it a useful identifier. Further-
more, our second study revealed that despite the
sampling only including residents from facilities that had
an active contract with a hospice service only half of the
EOL designated residents were receiving input from spe-
cialist services [20]. Our conclusion from these studies
was that there might be a more reliable way of predicting
death using the MDS given the breadth of data available.
On reviewing all items in the MDS we identified 50 that
could be related theoretically to the likelihood of death
within 6 months. The items were justified by existing
empirical research and clinical experience and fell into
four categories: demographics (e.g. age and sex); disease
(e.g. cancer, chronic heart failure); clinical signs and
symptoms (e.g. shortness of breath, poor appetite); and
adverse events (e.g. falls, hospitalisation, loss of a spouse).
With approval of the University of Missouri institutional
review board (IRB) and the appropriate data use agree-
ment, a dataset from the Missouri data was created of
residents using the first full MDS (annual or new admis-
sion) completed in 1999. The outcome, death of a resi-
dent within 6 months of the full MDS assessment, was
determined by linking the MDS data to Missouri death
certificate data using social security number, sex, and
date of birth. This produced a dataset with a full MDS
assessment and date of death information for a sample of
43,510 nursing home residents. The death rate in this
dataset over the 6 months follow-up was 26%. As
described in Porock et al. [16] stepwise logistic regression
methods along with a data-splitting strategy was
employed to develop a predictive model. The resulting
regression model included the following 14 independent
variables, listed in priority order for entry into the model:
d e pe n d e n cy  wi t h  a ct i vi t i es  o f  da i l y  l i vi n g,  s h o rt n es s  o f
breath, diagnosis of cancer, being an admission assess-
ment, having a poor appetite, being male, general physi-
cal deterioration, unintended weight loss over the past 90
days, chronic heart failure, increasing age, renal failure,
poor cognitive performance score, diagnosis of
Alzheimer's disease or dementia and dehydration. The
model also included interaction terms between age and
cancer and deterioration and admission, giving a final
model with 16 terms. A point-value for each risk factorPorock et al. BMC Research Notes 2010, 3:200
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was derived by transforming the associated logistic
regression coefficients to integer values, which are then
summed to give the MMRI score. Depending on the
selected "cut-point" the summated scale scores can pro-
vide a highly sensitive or highly specific instrument.
In developing the original MMRI, the goal was to pro-
vide  s im p le  yet  a c cu ra t e  i nst rum e n t  t ha t  c oul d pr edict
short term mortality. In practice the calculation of a hier-
archical Activities of Daily Living (ADL) score [21] and
the Cognitive Performance Scale (CPS) [22] were too
complex to be easily implemented by hand. As the
authors and others attempted to use the MMRI we found
using the algorithms too unwieldy and time consuming
[23]; the computations were confusing and the number of
variables excessive.
The modification of the MMRI was undertaken with
two research questions in mind. First, can a simpler ADL
and Cognitive performance measure produce an equally
strong model? Secondly, can we eliminate some of the
variables while maintaining predictive validity?
Methods
Modifying the MMRI
With the opportunity to review the MMRI we carefully
considered the theoretical and statistical implications of
each item as well as the practical issues of dealing with
the ADL and CPS scores. The original MMRI included
the item "deterioration" which was based on MDS item
Q2 (Overall Change in Care Needs). On review, the defi-
nition of this item seemed vague with a high risk of poor
reliability between raters. We decided to try the model
without this variable
Modifying the ADL score
The MDS includes a number of ordinal items the reflect
the degree of assistance required over the previous seven
days in performing typical activities of daily living (ADL)
such as bed transfers, eating, dressing and locomotion.
Items are scored on a 5 point scale: 0 = independent to 4
= total dependence. The MDS provides clear definitions
of the ordinal scaling (see Additional File 1). Morris et al.
[21] proposed a variety of ways of aggregating the items
into ADL scales. Based on face validity the MMRI
adopted the hierarchical ADL scale [21] but in practice
this proved too complex for routine use. Thus we consid-
ered replacing it with a simple summated scale and con-
sidered as alternatives the long-form, short-form, early-,
middle-, and late-loss ADL scales proposed by Morris et
al. [21]. We decided to use the short-form because it was
parsimonious and valid.
Modifying the CPS score
Calculation of the CPS [22] was another aspect of the
original MMRI that proved too cumbersome for routine
use without software. Five individual MDS items were
considered as replacements for the CPS: Indicators of
short- and long-term recall (MDS items b2a & b2b), a sin-
gle ordinal item on impairment in daily decision making
(b4), and an item reflecting stability, improvement or
deterioration in cognitive skills over the previous 90 days
(b6). The cognitive-change item was recoded to an indi-
cator of cognitive deterioration versus no-change or
improvement. Although the Alzheimer's/Dementia diag-
nosis variable had been predictive in the original analysis
we decided not to include it as the important factor in
predicting mortality is the change in cognitive function
rather than the formal diagnosis.
Following a procedure essentially identical to those
used to develop the original risk index and using the same
raw data set, the total data was split randomly 75%/25%
into development and validation data sets. Twenty ran-
dom subsets each consisting of approximately 10,800
subjects were drawn from the development data. Logistic
regression with stepwise selection was performed on
each subset and the frequency and entry step of each can-
didate replacement variable was recorded. Selection on
multiple subsets of the data help to avoid the biases and
'fluke' results associated with variable selection methods
[24]. Following selection of the replacements for the hier-
archal ADL scale and CPS, two way interactions involving
the new predictors were examined.
Results
Validating the new MMRI
The Short-Form ADL Scale [21] was the first variable to
enter on 19 of the 20 random subsets and so this four
item scale was adopted as the replacement for the hierar-
chical ADL scale. Of the candidate replacements for the
CPS the MDS item for change in cognitive status (b6) was
the most frequently selected cognitive variable entering
on 12 of 20 subsets. There was not a statistically signifi-
cant difference (p > 0.05) in the probability of death for
those with stable versus improving cognitive status and
so the item was recoded to an indicator of cognitive dete-
rioration. The only interaction effect added to the model
was between cognitive deterioration and the new ADL
scale. In the revised model age categories were revised to
a uniform set of five year increments.
Table 1 gives the regression model used to derive the
MMRI-R points system. Area under the ROC curve is a
commonly used measure of a model's ability to discrimi-
nate between observed outcomes. For the revised regres-
sion model the ROC area was 0.76 and Hosmer-
Lemeshow goodness-of-fit test [25] indicated adequate fit
with p = 0.16. As a final step in evaluating the regression
model we fit a logistic regression model with six month
mortality as the outcome and the MMRI-R score as the
only independent variable.
To form the MMRI-R scoring system, weights were
a s s i g n e d  t o  e a c h  v a r i a b l e  b y  r e s c a l i n g  t h e  e s t i m a t e dPorock et al. BMC Research Notes 2010, 3:200
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regression coefficients to integer values. Tables of tabu-
lated values for the interaction effects suggested cut-
points for these terms. The Additional File 1 gives the
revised point system. The theoretical range of MMRI-R is
0 to 85 with larger values indicating greater short-term
mortality risk. For our sample the mean score was 24 with
a standard deviation of 10 points and a range from 0 to
75. The Spearman correlation between risk scores on the
original and revised MMRI was 0.95 (p < 0.0001). Figure 1
displays the observed percent of residents who died and
the model-predicted mortality at each value of MMRI-R
score. Overall agreement is quite good with deviations
mostly at the extreme end of the score range where death
within six months is almost certain. This indicates that
the complexity of the original regression model is cap-
tured well in the MMRI-R score. Area under the ROC
curve for the single variable model is identical to the orig-
inal model.
Table 2 provides the frequency distribution of MMRI-R
values and six month mortality for five point increments
of the MMRI-R score distribution. Figure 1 is a plot of the
conditional probability of death given each MMRI-R
score or one greater. Thus for example, the estimated
probability of dying within six months given an MMRI-R
score of 34 or greater is .40 and and with a score of 50 or
greater the probability is approximately 0.80. Six month
mortality in the total sample is 23.3% and so this is the
value associated with an MMRI-R ≥ 0. Table 3 provides
estimates of sensitivity, specificity, predictive value posi-
tive (PVP), and predictive value negative (PVN) rates as
well as a calculation of Predictive Summary Index (PSI)
[26] when a prediction of death within six months is
made using the low boundary of the categories in the
table as decision points. For example, if an MMRI-R score
of 41 or greater is used as the criterion value, then one
would expect this prediction to be almost 99% specific
but not very sensitive (11.3%). The choice of a cut-point
will depend on what types of errors are most important
for the circumstance. In combination Additional File 1
and Table 3 should be useful for choosing a decision rule
for a particular application. Sensitivity and specificity are
informative measures of a predictive or diagnostic test's
performance however they do not directly address the
questions of greatest interest to the clinician, namely
given a test result, or MMRI-R score in this study, what is
the probability of survival. PVP and PVN rates are more
useful from the clinicians perspective in determining the
correctness of a decision than the sensitivity and.
Discussion
Using the MMRI-R
The MMRI-R is currently being tested as part of a 5 year
NIHR programme grant (National Institute for Health
Research; PI Prof J Gladman). A potential limitation of
the model may be that we do not know the validity of the
definitions of items in the MDS for practice. The current
study will help to determine the answer to that question.
However, the new predictive model demonstrates a simi-
Table 1: Revised Logistic Regression Model - Development Data
95% Confidence Limits
Variable Regression Coefficient Odds Ratio Lower Upper
Intercept -5.523 0.00 0.00 0.01
Sex 0.550 1.73 1.64 1.83
Admission 0.760 2.14 2.02 2.26
Shortness of Breath 0.820 2.27 2.11 2.45
Appeite 0.411 1.51 1.42 1.60
Weight Loss 0.459 1.58 1.48 1.69
Congestive Heart Failure 0.362 1.44 1.36 1.52
Renal failure 0.645 1.91 1.68 2.16
Dehydrated 0.402 1.49 1.33 1.68
Cancer 5.138
Age 0.026
Cancer*Age -0.051
ADL 0.104
Cognitive Deterioration -0.171
ADL * Cognitive Deterioration 0.045
Note: Odds ratios not calculated for variables included in interaction terms.Porock et al. BMC Research Notes 2010, 3:200
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lar accuracy to the original MMRI and the modifications
have been made with the same balance of statistical rigor
and clinical application.
The MMRI-R (Additional file 1) is designed to fit on
two sides of a single sheet of paper where the score can be
easily calculated by summing the relevant weighted
scores along with the calculated scores for the interaction
terms: "age and cancer"; and "ADL and cognitive decline".
At the bottom of the first page is a table indicating the
percentage of deaths in the original dataset for individual
scores divided into 5-point bands. From this, a health
professional could easily judge the likely prognosis of the
older person they are assessing.
For example, John, 72 years old, has been living in the
nursing home for about 6 months following the death of
his wife a year ago. John has CHF and some further cog-
nitive deterioration over the past three months and is
scoring 7 (mobility = 2; eating = 1; toilet use = 2; personal
hygiene = 2) on the ADL score but has a good appetite
would give a MMRI-R score of 19. From the data set 11%
of comparable older adults scoring 19 died in the follow-
ing 6 months. John's daughter wants to know if he should
undergo knee replacement surgery.
Another example is Marion, 75 years old with colon
cancer. She has become short of breath, is not so inter-
ested in food lately and she has lost some weight. She has
lived in the nursing home since her husband died two
Figure 1 Observed and Predicted Six Month Mortality by MMRI-R Score - Validation Data. Open circles denote observed mortality. Dots denote 
model-predicted average mortality and MMR-R value.
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months ago because without her husband to care for her,
her arthritis makes it increasingly difficult to manage
everyday activities. Marion's ADL score was 12 (mobility
3, eating 3, toilet use 3; personal hygiene 3) making her
total MMRI-R score 50. From the Missouri dataset, 69%
of comparable older adults died in the following 6
months. Marion's pain and shortness of breath is increas-
i n g  a n d  s h e  i s  a s k i n g  w h a t  t h i s  m e a n s .  T h e  M M R I - R
scores would help health professionals initiate conversa-
tions with John and Marion and provide meaningful
information for decision making about treatment choice
and preferences.
Of course there remain aspects of the assessed items
that are potentially reversible e.g. dehydration and others
potentially treatable for example shortness of breath may
be reduced with diuretics. These treatment decisions
w o u l d  b e  p a r t  o f  t h e  e n d  o f  l i f e  c a r e  d i s c u s s i o n .  T h e
M M R I - R  t h u s  a c t s  a s  a  p r o m p t  f o r  r e v i e w  o f  c u r r e n t
treatment as well as a prompt for EOL care planning. The
cut off score for suggesting that palliative goals of care be
discussed has not been determined and is for future
research to inform.
Conclusion
The MMRI-R is not designed nor has it been tested to be
any more than an aid to clinical judgement. The model
does not calculate when or of what an older person in a
long term care facility will die. It does not provide a defin-
itive prediction of whether someone will fall or acquire a
chest infection that ultimately turns out to be the termi-
nal event. What the MMRI-R score may provide is an
indication of risk of death when compared with older
adults in similar condition, the purpose of which is to
trigger conversations with residents and families and
assist in providing some context for end of life care plan-
ning.
Although using a prognostic score for death in older
residents may seem unusual, even distasteful, a salutary
lesson can be learned from the management of pain. A
commonly accepted practice across all settings of health-
care is the use of a simple visual analogue scale for mea-
suring pain; where 0 or 1 is no pain and 10 is the worst
pain imaginable. The simplicity of the tool and the con-
solidation of assessment can quickly spur practitioners to
respond confidently and appropriately. The benefits of
being able to have a reasonably accurate prediction of
prognosis that could similarly spur practitioners into hav-
ing EOL care planning conversations at the appropriate
time include: promoting individual choice in type and
place of care; to reductions in unnecessary admissions to
hospital; and initiation of futile treatments. We do not
know what the impact of giving professionals, residents
Table 2: Frequency Distribution of MMRI-R Scores and Mortality by 5-point Intervals - Development data for 6 month 
mortality
MMRI-R Risk Group Sample Size Percent of Sample Number of Deaths Percent Died
Overall 43311 100 10025 23
0-5 627 1.4 25 4
6-10 2986 6.9 120 4
11-15 5271 12.2 387 7
16-20 7706 17.8 881 11
21-25 8812 20.3 1530 17
26-30 7173 16.6 1925 27
31-35 4703 10.9 1710 36
36-40 2903 6.7 1377 47
41-45 1628 3.8 939 58
46-50 832 1.9 570 69
51-55 382 0.9 302 79
56-60 177 0.4 158 89
61-65 78 0.2 70 90
66-70 28 0.1 26 93
71-75* 5 0.0 5 100
* In our validation dataset the highest score is 75 however theoretically the score could be up to 85 which occurred in the development 
dataset. Given that all residents scoring over 70 died in the subsequent 6-months we would anticipate that scores 76 to 85 would also indicate 
an extremely high likelihood of death.Porock et al. BMC Research Notes 2010, 3:200
http://www.biomedcentral.com/1756-0500/3/200
Page 7 of 8
or families a score like this would have on decision mak-
ing and planning for end of life care. That will need to be
the subject of further research with which we hope this
simplified method will assist.
Additional material
Abbreviations
MMRI: MDS Mortality Risk Index; MMRI-R: MMRI-Revised; MDS: Minimum Data
Set.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
The following contributions were made by each author. DP contributed to the
conception of the research, interpretation of findings and drafting of the paper.
DPO also contributed to the conception of the research and the interpreta-
tions of findings. GP was responsible for data management and analysis, and
production of findings. MR provided access to the MDS database and consulta-
tion on research. All authors were involved in editing of the paper and have
read and approved the final manuscript.
Authors' information
Davina Porock RN PhD
Professor of Nursing Practice, The University of Nottingham
Adjunct Professor at University of Missouri and Edith Cowan University, Perth,
WA
Davina Porock RN PhD
The University of Nottingham
B46, South Block, Queen's Medical Centre
Nottingham, NG7 2HA, UK
+44 (0)115 8230813 (tel)
+44 (0)115 8231208 (fax)
http://davina.porock@nottingham.ac.uk
Debra Parker-Oliver MSW PhD
Associate Professor, Department of Family and Community Medicine
University of Missouri-Columbia, USA
Gregory F. Petroski PhD
Biostatistician, University of Missouri-Columbia, USA
Marilyn Rantz RN PhD FAAN
Professor of Nursing, Sinclair School of Nursing
University of Missouri-Columbia, USA
Author Details
1School of Nursing, Midwifery and Physiotherapy, The University of 
Nottingham, Nottingham, UK, 2Sinclair School of Nursing, University of 
Missouri-Columbia, Columbia, Missouri, USA, 3School of Nursing, Edith Cowan 
University, Perth, Western Australia, Australia, 4Department of Family and 
Community Medicine, University of Missouri-Columbia, Missouri USA, 5Office 
of Medical Research, University of Missouri-Columbia, Missouri, USA and 
6Sinclair School of Nursing, University of Missouri-Columbia, Missouri, USA
Additional file 1 the MMRI-R. The file contains the MMRI-R scoring sheet.
Table 3: Sensitivity, Specificity, and Predictive Value Positive (PVP) and Predictive Value Negative (PVN) Rates, and 
Predictive Summary Index (PSI) for Different MMRI-R "Cut-Points" - Validation Data
MMRI-R Cut-Point Sensitivity Specificity PVP PVN PSI
0 100.00 23.15
6 99.75 1.81 23.43 96.01 0.19
11 98.55 10.42 24.89 95.99 0.21
16 94.69 25.09 27.57 94.01 0.22
21 85.91 45.60 32.23 91.48 0.24
26 70.64 67.47 39.54 88.41 0.28
31 51.44 83.24 48.03 85.06 0.33
36 34.38 92.23 57.14 82.35 0.39
41 20.65 96.82 66.13 80.20 0.46
46 11.28 98.89 75.30 78.73 0.56
51 5.60 99.67 83.73 77.81 0.62
56 2.58 99.91 89.93 77.30 0.67
61 1.01 99.97 90.99 77.03 0.68
66 0.31 99.99 93.94 76.91 0.71
71 0.05 100.00 100.00 76.86 0.77
Table notes:
• Sensitivity is the probability of observing an MMRI-R score greater than or equal to the cut-point given mortality within six months.
• Specificity is the probability of observing an MMRI-R score less than the cut-point given survival beyond six months.
• Predictive value positive (PVP) and is the probability of dying within six months given an MMRI-R score is greater than or equal to the cut 
point.
• Predictive value negative (PVN) and is the probability of surviving beyond six months given an MMRI-R score less than the cut-point.
• The appropriateness of PVP and PVN depends on having a good estimate of population prevalence, in this case the prevalence of six month 
mortality.
• For ease of interpretation all probabilities were converted to percentages.
• Predictive Summary Index (PSI), calculated as PVP + PVN -100, is a overall measure of the gain in certainty associated with using the MMRI-
R to make decisions. The practical range of PSI values is 0 to 1 with 0 reflecting a useless test and PSI = 1 for a test yielding perfect predictions.Porock et al. BMC Research Notes 2010, 3:200
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